Logo image
Abstract LB-B002: A phase 1 trial of the oncolytic virus SVV-001 with Nivolumab and Ipilimumab in patients with high grade Neuroendocrine Neoplasms
Abstract   Peer reviewed

Abstract LB-B002: A phase 1 trial of the oncolytic virus SVV-001 with Nivolumab and Ipilimumab in patients with high grade Neuroendocrine Neoplasms

Aman Chauhan, Isildinha M. Reis, Chinmay Jani, Rakhi Modak, Daniel Bilbao Cortes, Stephanie Baboun, Alexander Rivera, Hung Trinh, Paul Hallenbeck, Jaime Merchan, …
Cancer immunology research, Vol.14(2_Supplement), pp.LB-B002-LB-B002
2026-03-18

Metrics

1 Record Views

Details

Logo image